These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2309514)

  • 1. A team approach to reduce antibiotic costs.
    Karki SD; Holden JM; Mariano E
    DICP; 1990 Feb; 24(2):202-5. PubMed ID: 2309514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacy-laboratory interactions: a unique method to control antibiotic costs.
    Goff D; Thornton J
    Hosp Pharm; 1989 Jan; 24(1):26-9, 32. PubMed ID: 10291600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing prophylactic antibiotic costs in cardiovascular surgery: the role of the clinical pharmacist.
    Peterson CD; Lake KD
    Drug Intell Clin Pharm; 1986 Feb; 20(2):134-7. PubMed ID: 3948689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic optimization. An evaluation of patient safety and economic outcomes.
    Fraser GL; Stogsdill P; Dickens JD; Wennberg DE; Smith RP; Prato BS
    Arch Intern Med; 1997 Aug 11-25; 157(15):1689-94. PubMed ID: 9250230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital.
    Woodward RS; Medoff G; Smith MD; Gray JL
    Am J Med; 1987 Nov; 83(5):817-23. PubMed ID: 3674089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A team approach to hospital formulary replacement.
    Lee J; Carlson JA; Chamberlain MA
    Diagn Microbiol Infect Dis; 1995; 22(1-2):239-42. PubMed ID: 7587047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Culture and antibiotic monitoring service in a community hospital.
    Von Seggern RL
    Am J Hosp Pharm; 1987 Jun; 44(6):1358-62. PubMed ID: 3303924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of an operational multidisciplinary team on hospital antibiotic use and cost in France: a cluster controlled trial.
    Bevilacqua S; Demoré B; Erpelding ML; Boschetti E; May T; May I; Rabaud C; Thilly N
    Int J Clin Pharm; 2011 Jun; 33(3):521-8. PubMed ID: 21437676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic therapy intervention at a community hospital. Opportunities for cost and quality improvements.
    Thrasher CM; Stefl ME; Dorner FH
    Hosp Top; 1995; 73(2):12-5. PubMed ID: 10144621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of pharmacist interventions.
    Torchinsky A; Landry D
    Can J Hosp Pharm; 1991 Oct; 44(5):245-8, 270. PubMed ID: 10115578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in antibiotic costs by restricting use of an oral cephalosporin.
    Seligman SJ
    Am J Med; 1981 Dec; 71(6):941-4. PubMed ID: 7315856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of pharmacist interventions on rational prophylactic antibiotic use and cost saving in elective cesarean section.
    Wang J; Dong M; Lu Y; Zhao X; Li X; Wen A
    Int J Clin Pharmacol Ther; 2015 Aug; 53(8):605-15. PubMed ID: 26104036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pharmacist participation on a medical team on costs, charges, and length of stay.
    Haig GM; Kiser LA
    Am J Hosp Pharm; 1991 Jul; 48(7):1457-62. PubMed ID: 1882873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic cost control measures in a hospital pharmacy.
    Manzo J; Amodio-Groton MA; Kleinmann K
    Clin Ther; 1993; 15 Suppl A():37-43. PubMed ID: 8513460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a clinical pharmacist on antibiotic prescribing. A multicenter trial.
    Thornton JP; Goff DA; Segal R; Guy JT
    J Pharm Technol; 1991; 7(5):195-200. PubMed ID: 10115343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the impact of education by a clinical pharmacist on antibiotic prescribing and administration in an acute care state psychiatric hospital.
    Thompson BF; Miller WA; Wells BG; Rawls WN
    Hosp Pharm; 1986 Nov; 21(11):1056-62. PubMed ID: 10279323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing the duration of prophylactic antibiotic use through computer monitoring of surgical patients.
    Evans RS; Pestotnik SL; Burke JP; Gardner RM; Larsen RA; Classen DC
    DICP; 1990 Apr; 24(4):351-4. PubMed ID: 2327113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of an antibiotic cost containment measure.
    Jung B; Andrews JD
    Can J Hosp Pharm; 1990 Jun; 43(3):116-22. PubMed ID: 10105649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Financial impact of formulary revision of second-generation cephalosporins.
    Andrews JD; Hafting S
    Can J Hosp Pharm; 1988 Jun; 41(3):125-7. PubMed ID: 10288499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital.
    Boyko WL; Yurkowski PJ; Ivey MF; Armitstead JA; Roberts BL
    Am J Health Syst Pharm; 1997 Jul; 54(14):1591-5. PubMed ID: 9248601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.